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Diagnosis of Variant Angina
Outdated Trick of the Trade or a Resurgent
Diagnostic Modality?*Ibhar Al Mheid, MD, Salim Hayek, MD, Arshed A. Quyyumi, MDI n 1959, Prinzmetal et al. (1,2) reported on 32 pa-tients with a form of angina pectoris that wasnot generally precipitated by increased cardiac
workload, as described by Heberden (3). During
an attack of this variant type of angina, Prinzmetal
et al. noted that ST segments were transiently and
often markedly elevated, did not resolve with rest,
and occurred in a cyclic fashion with a predilection
for the early morning hours. This seminal report pro-
posed “temporary increased tonus of a large nar-
rowed coronary artery” as a possible cause of these
attacks (1,2).
Variant angina (VA) is now known to be caused by
vasospasm of an epicardial artery, typically, but not
invariably, in segments with insigniﬁcant athero-
sclerosis (4,5). Even when an epicardial artery ap-
pears to be angiographically normal, atherosclerotic
plaques can be demonstrated within a centimeter of
the spastic site by intravascular ultrasonography
(6,7). In some patients, VA may involve more than 1
artery and may occur either simultaneously or ﬂuc-
tuate between different epicardial vessels. Proposed
etiologies include abnormalities in nitric oxide
signaling and smooth muscle hypertrophy or hyper-
sensitivity, among others (8–10).
Irrespective of the presence or severity of obstruc-
tive atherosclerotic disease, coronary spasm often
results in myocardial ischemia and causes anginal*Editorials published in the JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
From the Emory Clinical Cardiovascular Research Institute, Atlanta,
Georgia. The authors have reported that they have no relationships
relevant to the contents of this paper to disclose.symptoms. Transmural ischemia of a large area of the
myocardium can result in ventricular arrhythmias
and heart failure, and prolonged attacks may lead to
thrombus formation and infarction (11,12). Several
physiological stimuli can provoke coronary vaso-
spasm including exercise, mental stress, hyperven-
tilation, and cold exposure. However, these are
unreliable stressors for diagnostic purposes (13,14).
In the context of preserved exercise tolerance and
normal stress imaging, the presence of ST-segment
deviation recorded during an attack that occurs
at rest and resolves with nitrate administration
readily identiﬁes patients with VA. Ambulatory
monitoring and provocative testing are often neces-
sary to conﬁrm the diagnosis (15).
Although VA is uncommon compared with other
coronary syndromes, its true incidence and preva-
lence remain unknown. In some patients, symptoms
may be exertional due to exercise-provoked vaso-
spasm, there may be systemic vasospastic diathesis,
or the vasomotor instability may resolve over time
after an acute coronary syndrome (16–18). Pharma-
cological provocation, with intracoronary acetylcho-
line or with intravenous or intracoronary ergonovine
has been used to diagnose vasospasm and has a
sensitivity of w90% in patients with VA compared
with a w4% to 5% rate of vasospasm observed in
patients referred for diagnostic angiography (19). The
sensitivity and speciﬁcity of intracoronary ergono-
vine are higher than intravenous ergonovine and
similar to that of acetylcholine (19).
The vasoconstrictor response to ergonovine is
mediated by endothelium-independent contraction
of vascular smooth muscle and typically involves
proximal coronary segments (20). Acetylcholine
stimulates nitric oxide production by endothelial
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925cells while simultaneously exerting direct contractile
effects on vascular smooth muscle cells. When en-
dothelial cell activity is preserved, the vasodilator
response predominates and usually overwhelms
any constrictive effects (21). However, with endo-
thelial dysfunction, the contractile effects of ace-
tylcholine remain unopposed, and vasoconstriction
ensues (15,22,23).
The optimal provocation procedure in terms of
safety and diagnostic utility has yet to be deﬁned.
Controversies surround the choice and doses of
the provocative agent (ergonovine vs. acetylcholine),
infusion route (intracoronary vs. intravenous), and
the deﬁning criteria of coronary spasm. Most studies
have used the precipitation of greater than 90%
focal or diffuse coronary narrowing during provoca-
tive testing, together with the development of angina
and ischemic electrocardiographic changes for the
diagnosis of VA, whereas other reports have used
narrowing greater than 75% as diagnostic (19,20).
There is also controversy regarding whether diffuse
coronary constriction, diagnostic of endothelial dys-
function when provoked by intracoronary acetylcho-
line, should even be considered diagnostic of VA and
whether this should only be diagnosed when there
is focal epicardial spasm (22). More recently, the
term microvascular spasm has been used when
provocation with intracoronary acetylcholine results
in the clinical syndrome of angina, ischemic electro-
cardiographic changes, and/or reduction in coronary
blood ﬂow, but with little or no epicardial vasocon-
striction (24–26).
Provocative testing with ergonovine and acetyl-
choline is relatively safe (27). Adverse effects are
usually benign such as headache and nausea, but
provocation can potentially result in life-threatening
sequelae including ventricular arrhythmias, com-
plete heart block, refractory coronary spasm, and
myocardial infarction. Testing for coronary spasm
should therefore be performed with caution by well-
trained operators equipped for delivery of percuta-
neous therapeutics, especially in patients with
obstructive coronary artery disease.SEE PAGE 914In this issue of JACC: Cardiovascular Interventions,
Shin et al. (28) report ﬁndings from a multicenter
registry of Korean patients who were free of
obstructive coronary artery disease and were evalu-
ated for VA using intracoronary ergonovine. Based on
their coronary vasomotor response, more than 2,000
patients were classiﬁed into positive (>90% stenosis),
intermediate (50% to 90%) and negative (<50%)
groups for vasospasm that constituted 21%, 46%, and32% of study patients, respectively. The majority of
positive patients had diffuse rather than focal coro-
nary spasm, experienced more severe and recurrent
attacks of angina, had higher rates of hospitalization
for angina, and higher levels of circulating C-reactive
protein levels compared with their counterparts.
Patients in the positive group were more often male,
had the highest rate of smoking, and appeared to
have a higher rate of adverse events including cardiac
death, acute coronary syndromes, and ventricular
arrhythmia during a 2-year follow-up. However, the
incomplete or absent follow-up in patients in the
intermediate and negative spasm groups makes the
relatively low adverse event rate in the spasm-
positive group difﬁcult to interpret.
The report by Shin et al. (28) nevertheless provides
contemporary data necessary to advance the ﬁeld of
coronary vasoreactivity and provocative testing and
highlights a true collaborative effort among multiple
institutions in South Korea. Strengths include its
large population size and implementation of a clearly
deﬁned protocol in centers with established exper-
tise. Longer follow-up of all study patients will be
required to ascertain whether morbidity and mortal-
ity are inﬂuenced by the type of ergonovine response,
particularly in the intermediate responders, the most
common form of test result observed.
Although earlier reports have suggested that VA
occurs more frequently in Asians, recent larger
studies in European patients suggest that the fre-
quency of vasomotor abnormalities during provoca-
tive testing in patients without obstructive coronary
artery disease may be similar to that in Asians (29,30).
For example, in a series of 900 consecutive patients
without obstructive coronary artery disease, intra-
coronary acetylcholine provoked signiﬁcant spasm
(greater than 75% narrowing) in one-third of study
patients. Microvascular spasm, deﬁned by the pres-
ence of angina and ischemic electrocardiographic
shifts in the absence of signiﬁcant epicardial vaso-
constriction, occurred in nearly one-fourth of pa-
tients. Unlike the Asian experience, both epicardial
and microvascular spasm occurred more frequently in
women, and smoking frequency was not greater in
those with microvascular spasm (29).
The ﬁeld of coronary provocative testing remains
challenging for the practicing physician. Ergonovine
may not yield information similar to that of acetyl-
choline testing, although there is a clear overlap be-
tween these agents. It is likely that the substrate,
treatment, and prognosis of patients with focal
epicardial spasm (classic VA), diffuse epicardial
spasm, and microvascular spasm are dramatically
different. For example, patients with epicardial
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926spasm respond to calcium antagonists and nitrates
and may need to be taken off beta-antagonists,
whereas those with more diffuse epicardial or mi-
crovascular spasm are likely best treated by agents
that improve endothelial function such as statins,
angiotensin antagonists, and arginine (23,31).
The most common ﬁnding with provocative testing
is an intermediate response that is neither diagnostic
of spasm nor entirely normal. The lack of long-term
follow-up of these patients makes interpretation
of these ﬁndings problematic. In the United
States, ergonovine is not readily available, althoughergometrine may offer an alternative. Acetylcholine
testing is performed at a few centers only; neverthe-
less, provocative testing implemented in patients
with persistent anginal symptoms but nonobstructive
coronary disease can often be diagnostic and is reas-
suring for patients and often results in a more deﬁned
therapeutic strategy.
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